Long COVID, also known as post-COVID condition, is defined by a wide range of physical and mental health problems that linger for about 4-to-12 weeks after a SARS-CoV-2 infection, and occasionally, longer.
As COVID-19 restrictions are lifted and clinical testing is generally limited to diagnostic purposes in healthcare facilities, the full extent of SARS-CoV-2 infection is largely unknown.
In a study published in CMAJ, CITF experts Drs. David Buckeridge and Mathieu Maheu-Giroux from McGill University and Sharmistha Mishra from the University of Toronto used COVID-19 surveillance data from Jan 23, 2020, to Feb 28, 2021 to identify relevant social determinants of health – those factors influencing health outcomes that go beyond the strictly medical in metropolitan centres in Canada.
Canada has opted to ensure the wide availability of rapid antigen tests for COVID-19. These devices, named for their ability to detect active SARS-CoV-2 infections within one hour, have garnered mixed reviews.
Many people who are pregnant, or are thinking about getting pregnant, are concerned about COVID-19 vaccines. The scientific evidence, however, clearly supports the benefits of vaccination for the pregnant person and the newborn.
Solid organ transplant recipients (SOTRs) face profound disturbances to their immune system due to prolonged exposure to immunosuppressive drugs, which make them generally more susceptible to infections such as SARS-CoV-2.
Solid organ transplant recipients (SOTRs) face profound disturbances to their immune system due to prolonged exposure to immunosuppressive drugs, which make them generally more susceptible to infections such as SARS-CoV-2.
Solid organ transplant recipients (SOTRs) face profound disturbances to their immune system due to prolonged exposure to immunosuppressive drugs, which make them generally more susceptible to infections such as SARS-CoV-2.
Dr. Jeffrey Kwong from the University of Toronto contributed to a recent publication in the Annals of Epidemiology that illustrates the disproportionate toll COVID-19 has taken among individuals who self-identify as visible minorities and who live in the lowest income areas of Toronto.
Dr. Danuta Skowronski and colleagues from the BC Centre for Disease Control evaluated the real-world single-dose effectiveness (as opposed to the findings of clinical trials) of the Pfizer, Moderna and AstraZeneca vaccines.